Commerce Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1M Buy
281,810
+32,127
+13% +$1.87M 0.08% 186
2025
Q4
$13.5M Sell
249,683
-17,356
-6% -$835K 0.07% 183
2025
Q3
$12M Sell
267,039
-11,900
-4% -$556K 0.07% 188
2025
Q2
$12.9M Sell
278,939
-16,566
-6% -$813K 0.08% 178
2025
Q1
$18M Sell
295,505
-4,144
-1% -$242K 0.12% 146
2024
Q4
$16.9M Sell
299,649
-18,863
-6% -$1.05M 0.1% 145
2024
Q3
$16.5M Sell
318,512
-30,241
-9% -$1.42M 0.1% 150
2024
Q2
$14.5M Sell
348,753
-177,979
-34% -$7.96M 0.09% 159
2024
Q1
$28.6M Buy
526,732
+340
+0.1% +$17.3K 0.19% 112
2023
Q4
$27M Buy
526,392
+98,784
+23% +$5.19M 0.19% 112
2023
Q3
$24.8M Sell
427,608
-57,646
-12% -$3.53M 0.2% 107
2023
Q2
$31M Sell
485,254
-58,073
-11% -$3.89M 0.23% 96
2023
Q1
$37.7M Buy
543,327
+12,565
+2% +$886K 0.3% 84
2022
Q4
$38.2M Buy
530,762
+94,229
+22% +$7.1M 0.31% 83
2022
Q3
$31M Buy
436,533
+7,222
+2% +$524K 0.27% 91
2022
Q2
$33.1M Buy
429,311
+11,253
+3% +$857K 0.27% 92
2022
Q1
$30.5M Sell
418,058
-7,769
-2% -$522K 0.21% 112
2021
Q4
$26.6M Sell
425,827
-8,484
-2% -$498K 0.17% 126
2021
Q3
$25.7M Buy
434,311
+14,698
+4% +$968K 0.18% 126
2021
Q2
$28M Sell
419,613
-6,060
-1% -$395K 0.2% 118
2021
Q1
$26.9M Buy
425,673
+10,572
+3% +$658K 0.2% 114
2020
Q4
$25.7M Sell
415,101
-934
-0.2% -$57.4K 0.21% 108
2020
Q3
$25.1M Sell
416,035
-1,941
-0.5% -$117K 0.23% 100
2020
Q2
$24.6M Buy
417,976
+6,125
+1% +$366K 0.24% 96
2020
Q1
$23M Sell
411,851
-1,704
-0.4% -$104K 0.28% 92
2019
Q4
$26.5M Buy
413,555
+127,746
+45% +$7.32M 0.25% 99
2019
Q3
$14.5M Sell
285,809
-925
-0.3% -$43.5K 0.15% 122
2019
Q2
$13M Sell
286,734
-2,201
-0.8% -$103K 0.15% 124
2019
Q1
$13.8M Sell
288,935
-835
-0.3% -$41.6K 0.16% 116
2018
Q4
$15.1M Sell
289,770
-21,582
-7% -$1.16M 0.19% 109
2018
Q3
$19.3M Sell
311,352
-10,413
-3% -$618K 0.23% 104
2018
Q2
$17.8M Sell
321,765
-3,173
-1% -$171K 0.23% 106
2018
Q1
$20.6M Sell
324,938
-1,522
-0.5% -$97.9K 0.27% 96
2017
Q4
$20M Buy
326,460
+2,870
+0.9% +$180K 0.26% 98
2017
Q3
$20.6M Buy
323,590
+404
+0.1% +$23.6K 0.28% 92
2017
Q2
$18M Buy
323,186
+3,132
+1% +$170K 0.25% 104
2017
Q1
$17.4M Buy
320,054
+777
+0.2% +$42.6K 0.25% 104
2016
Q4
$18.7M Buy
319,277
+6,434
+2% +$352K 0.28% 91
2016
Q3
$16.9M Sell
312,843
-11,149
-3% -$716K 0.26% 99
2016
Q2
$23.8M Sell
323,992
-17,627
-5% -$1.25M 0.38% 71
2016
Q1
$21.8M Sell
341,619
-16,479
-5% -$1.04M 0.36% 76
2015
Q4
$24.6M Sell
358,098
-2,349
-0.7% -$155K 0.41% 68
2015
Q3
$21.3M Sell
360,447
-16,727
-4% -$1.06M 0.37% 77
2015
Q2
$25.1M Sell
377,174
-1,520
-0.4% -$100K 0.39% 70
2015
Q1
$24.4M Sell
378,694
-11,270
-3% -$706K 0.38% 75
2014
Q4
$23M Sell
389,964
-32,352
-8% -$1.82M 0.36% 76
2014
Q3
$21.6M Buy
422,316
+3,313
+0.8% +$165K 0.36% 74
2014
Q2
$20.3M Sell
419,003
-4,650
-1% -$229K 0.33% 78
2014
Q1
$22M Buy
423,653
+4,761
+1% +$253K 0.37% 67
2013
Q4
$22.3M Buy
418,892
+5,729
+1% +$292K 0.39% 67
2013
Q3
$19.1M Sell
413,163
-3,740
-0.9% -$164K 0.34% 69
2013
Q2
$18.6M Buy
+416,903
New +$18.1M 0.35% 72

Other funds holding BMY

Commerce Bank's BMY Position: Q1 2026 in Review

Commerce Bank increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $1.87M and bringing the position to 281,810 shares worth $17.1M. The position accounts for 0.08% of the portfolio, ranked #186.

Commerce Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.2M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Commerce Bank held 281,810 shares of Bristol-Myers Squibb worth $17.1M as of Q1 2026.
  • Commerce Bank bought 32,127 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.87M.
  • Bristol-Myers Squibb made up 0.08% of Commerce Bank's portfolio in Q1 2026, its #186 holding.
  • Commerce Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Commerce Bank's Bristol-Myers Squibb position peaked at $38.2M in Q4 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.